By www.reliablebusinessinsights.com
Global IBS Treatment Market Research Report 2023 Story
111
$ 2900
IBS Treatment Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Allergan (Ireland) Sucampo Pharmaceuticals (U.S.) Ironwood Pharmaceuticals (U.S.) Astellas Pharma (Japan) Bausch Health Abbott Laboratories (U.S.) Synergy Pharmaceuticals (U.S.) Ardelyx (U.S.) Nestle (Switzerland) Sebela Pharmaceuticals (Ireland) Probi (Sweden) Alfasigma USA (Italy) RedHill Biopharma (Israel) AstraZeneca (U.K) Ipsen (France) Novartis (Switzerland) Takeda Pharmaceutical Company (Japan) Synthetic Biologics (U.S.) Protagonist Therapeutics (U.S.) Pfizer (U.S.) Lexicon Pharmaceuticals (U.S.) Innovate Biopharmaceuticals (U.S.)